Glow Blend is a research-supply formulation pairing three peptides at fixed proportions in a single lyophilized vial: GHK-Cu (50 mg), BPC-157 (10 mg), and TB-500 (10 mg) — 70 milligrams of peptide total. Each component compound is also available standalone from Ronin Peptides; the blend format pairs them at convenient working concentrations for combined-compound benchwork. The three components engage three non-overlapping mechanism niches across the skin-and-tissue-repair research landscape. Ronin supplies the blend as a lyophilized vial reconstituted with bacteriostatic water at the bench. Sale is limited to laboratory research applications; human and veterinary use are excluded.

Why a blend rather than individual compounds?

Researchers studying combined-compound protocols often investigate GHK-Cu, BPC-157, and TB-500 together because the three compounds engage distinct molecular pathways that do not compete at the receptor or signalling-pathway level. The blend format provides convenient working concentrations at fixed ratios for combined-compound benchwork, removing the need to reconstitute three separate vials and combine them at the bench. Researchers who prefer to control individual concentrations independently can use the standalone single-compound vials for each component instead.

What are the per-component concentrations after reconstitution?

A single 70 mg vial reconstituted with 2 mL of bacteriostatic water yields GHK-Cu at 25 mg/mL, BPC-157 at 5 mg/mL, and TB-500 at 5 mg/mL simultaneously. Other diluent volumes scale linearly. The three peptides share the same diluent volume but contribute distinct working concentrations corresponding to their per-vial loadings (50 mg, 10 mg, 10 mg respectively). Researchers should choose the reconstitution volume based on which component's working concentration is the primary experimental anchor.

What is the regulatory status of Glow Blend?

No regulatory body — Health Canada, the FDA, the EMA, the TGA, or any equivalent — has approved any of the three component compounds, or the blend formulation, as a drug for human or veterinary use. GHK-Cu carries cosmetic-ingredient approval under the INCI name Copper Tripeptide-1 in multiple jurisdictions; cosmetic ingredient approval is regulatorily distinct from drug approval and applies to the GHK-Cu component only. None of the three compounds, nor the blend, are listed as scheduled controlled substances under the international drug-control conventions or under the major national scheduling systems. The blend sits within the regulatory layer covering laboratory reagents and research chemicals. Ronin Peptides supplies the blend as a research-grade reagent for laboratory and bench-research applications. Buyers operate under their own jurisdictional laws and any applicable institutional review protocols when handling the compound — Ronin Peptides assumes no oversight of downstream lab practice.

How is Glow Blend verified?

Each batch passes through Janoshik Analytical — an independent peptide-analytics lab — for HPLC purity quantification of each of the three component compounds and MS identity confirmation of each component, with the minimum acceptance threshold set at 99 percent purity per component by HPLC. The COA shows three distinct mass-spec peaks corresponding to the three components. To pull the COA covering the batch on your order, email support@roninpeptides.ca from the address used at checkout, with your order number; the typical reply turnaround is well under 24 hours.

Why is the Glow Blend powder blue?

The blue tint comes from the GHK-Cu component specifically. The Cu(II) chromophore — the copper-2 ion bound at the histidine-imidazole chelation pocket of the GHK tripeptide — absorbs visible light in the orange-red wavelength range and transmits the complementary blue. The BPC-157 and TB-500 components do not contribute to the colour. Loss of the blue tint during storage signals dissociation of the GHK-Cu Cu(II) complex specifically, but does not directly indicate the status of the BPC-157 or TB-500 components, which require COA mass-spec data for status confirmation.

How is Glow Blend reconstituted?

The standard preparation is 2 mL of bacteriostatic water added to a 70 mg vial, producing a solution with GHK-Cu at 25 mg/mL, BPC-157 at 5 mg/mL, and TB-500 at 5 mg/mL. Inject the water against the inside wall of the vial — never directly onto the lyophilized powder, which causes foaming and surface denaturation. Swirl gently or invert slowly until fully dissolved (typically 30-60 seconds). The reconstituted solution should appear transparent with a blue tint. Refrigerate at 2-8 °C immediately after reconstitution. Use the Ronin reconstitution calculator for non-standard volumes or to convert per-component target doses to insulin-syringe units.

How do I receive the COA for my batch?

Email support@roninpeptides.ca from the email address used at checkout, with your order number (e.g., RP-CA-1234) and the compound name. We reply within 24 hours — typically the same business day — with the COA PDF attached. The COA includes the Janoshik verification key and per-component analytical results for the three blend components, which you can check independently at janoshik.com to confirm the test results match what the laboratory ran on your specific batch. COAs are not published publicly to protect supply-chain privacy and prevent competitor scraping.

Recovery Research

Glow Blend 70mg

Three-compound research blend: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg. Skin & tissue-repair research.

4.9 · 43 reviews

Rated 4.91 out of 5 based on 43 customer ratings

(43 customer reviews)

Purity: ≥99% per component by HPLC

From $144.99

SKU: GLOW-2732-A

Free shipping over $200
Interac + BTC
Same-day Canadian dispatch
Discreet packaging

Additional information

Pack Size	Single Vial, 10-Pack

Janoshik testedPer-component COA per batch

≥99% per componentHPLC + MS 3-peak verified

Ships from CanadaTracked Xpresspost

Studied in research literature

Skin & dermal repair research

Three-compound combined research framing across ECM remodelling, vascular signalling, and cell migration model systems.

Combined tissue-repair pathways

Non-overlapping mechanism niches engaged simultaneously across cardiac, dermal, and gastric research streams.

Convenient research-supply format

Fixed-ratio blend; per-peptide concentrations scale linearly with reconstitution volume.

Quality verification

Independent third-party HPLC + MS testing per batch

Batch: GLOW-2732-A
Lab: Janoshik Analytical
HPLC purity: 99.4% (per component)
MS identity: confirmed (3-peak)
Tested: 2026-05-01

Email for COA

COAs are not posted publicly. Email support@roninpeptides.ca from the address used at checkout, with your order number; reply within 24 hours.

Storage and handling

Lyophilized blendSealed amber vial

−20 °C unmixed2+ year stability

2–8 °C reconstitutedStable 4–6 weeks

Avoid lightCu(II) photostable dry; UV-sensitive wet

Important: research use only

Glow Blend 70mg is supplied by Ronin Peptides exclusively for laboratory and bench-research applications. Ronin makes no representation that this material is safe or effective in humans or animals, and nothing in this listing should be read as medical, veterinary, dietary, or therapeutic advice. No regulatory body, including Health Canada, the U.S. Food and Drug Administration, or the EMA, has reviewed this material as a drug for human or veterinary use. This listing describes what is in the vial, how it is tested, and how it is stored and shipped. Dosing protocols, administration routes, and application instructions are not provided. The buyer takes responsibility for compliance with all applicable jurisdictional law, institutional review, and laboratory-safety standards.

Glow Blend is a three-compound lyophilized preparation supplied as 70 mg of total peptide in one sealed glass vial.

What is in the vial

Each vial contains 50 mg GHK-Cu, 10 mg BPC-157, and 10 mg TB-500, for 70 mg of peptide content. Those are the same loadings Ronin fills into the corresponding single-compound vials, so the blend is a combined fill rather than a diluted one. The three compounds are brought into one solution before lyophilization and cannot be separated afterwards. If you need the same three with KPV added, that is the four-compound KLOW Blend rather than a variant of this vial.

Form and appearance

The cake is blue, taking its colour from the GHK-Cu fraction, which is the largest of the three by mass. Colour depth varies batch to batch. The cake may arrive whole or broken into fragments after transit; neither affects the contents. Like the single-compound vials, this product is filled dry with no excipients.

Purity and identity testing

Blends are tested per component, not as a single aggregate. An independent third-party laboratory resolves all three peptides by HPLC and reports a purity figure for each, with mass spectrometry confirming the identity of each peak. A three-peak result is the expected output for this product. Ronin releases nothing below 99 percent per component. Current certificates are on the lab results page, matched to the batch number on the label.

Storage

Hold unopened vials at 2 to 8 degrees Celsius for working stock or minus 20 degrees Celsius for longer storage, kept in the carton because the copper fraction is light-sensitive. After reconstitution, refrigerate and protect from light. As with any multi-component preparation, the three peptides will not remain stable over the same timeframe once in solution, so reconstituted blend is best handled as short-lived.

Reconstitution

Vials are shipped dry and are reconstituted in the laboratory before use. Ronin does not publish volumes, concentrations, or syringe markings on product listings. General handling guidance, including the properties of bacteriostatic water and sterile technique for drawing into a sealed vial, is kept on a single reference page: reconstitution and laboratory handling. Bacteriostatic Water 10mL is stocked separately and is not included with this vial.

Shipping

Orders ship from Canada by Canada Post with tracking supplied on dispatch. Lyophilized peptides are stable at ambient temperature for the duration of domestic transit, so vials ship without a cold chain and should be moved to their intended storage conditions on arrival. Vials are packed dry in the sealed glass they were filled in, with the stopper and crimp intact.